Recombinant multi-species RNF19A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF19A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the ring between ring fingers (RBR) protein family, and the encoded protein contains two RING-finger motifs and an in between RING fingers motif. This protein is an E3 ubiquitin ligase that is localized to Lewy bodies, and ubiquitylates synphilin-1, which is an interacting protein of alpha synuclein in neurons. The encoded protein may be involved in amyotrophic lateral sclerosis and Parkinson's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
The Alternative Names of target: Dorfin,Double ring-finger protein (Dorfin),E3 ubiquitin-protein ligase RNF19A,RING finger protein 19A,RNF19,RNF19A,Rnf19,Rnf19a,UIP117,Ubce7ip2,XYbp,p38

Target products collectionGo to RNF19A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1522-Ag-1/ GM-Tg-hg-IP1522-Ag-2 Human RNF19A protein Human
GM-Tg-rg-IP1522-Ag-1/ GM-Tg-rg-IP1522-Ag-2 Rat RNF19A protein Rat
GM-Tg-mg-IP1522-Ag-1/ GM-Tg-mg-IP1522-Ag-2 Mouse RNF19A protein Mouse
GM-Tg-cynog-IP1522-Ag-1/ GM-Tg-cynog-IP1522-Ag-2 Cynomolgus/Rhesus macaque RNF19A protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1522-Ag-1/ GM-Tg-felg-IP1522-Ag-2 Feline RNF19A protein Feline
GM-Tg-cang-IP1522-Ag-1/ GM-Tg-cang-IP1522-Ag-2 Canine RNF19A protein Canine
GM-Tg-bovg-IP1522-Ag-1/ GM-Tg-bovg-IP1522-Ag-2 Bovine RNF19A protein Bovine
GM-Tg-equg-IP1522-Ag-1/ GM-Tg-equg-IP1522-Ag-2 Equine RNF19A protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1522-Ag-1/ GM-Tg-hg-IP1522-Ag-2; GM-Tg-rg-IP1522-Ag-1/ GM-Tg-rg-IP1522-Ag-2;
GM-Tg-mg-IP1522-Ag-1/ GM-Tg-mg-IP1522-Ag-2; GM-Tg-cynog-IP1522-Ag-1/ GM-Tg-cynog-IP1522-Ag-2;
GM-Tg-felg-IP1522-Ag-1/ GM-Tg-felg-IP1522-Ag-2; GM-Tg-cang-IP1522-Ag-1/ GM-Tg-cang-IP1522-Ag-2;
GM-Tg-bovg-IP1522-Ag-1/ GM-Tg-bovg-IP1522-Ag-2; GM-Tg-equg-IP1522-Ag-1/ GM-Tg-equg-IP1522-Ag-2
Products Name RNF19A protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RNF19A
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF19A protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.